Healthcare (SH:603313)2016-12-12 16:00Financial Performance - Operating income for the first nine months rose by 24.06% to CNY 1,221,018,558.00 compared to the same period last year[7] - Net profit attributable to shareholders increased by 13.82% to CNY 141,897,680.91 for the first nine months compared to the same period last year[7] - Basic earnings per share increased by 14.49% to CNY 0.79 compared to the same period last year[7] - The company reported a weighted average return on equity of 20.72%, down from 22.52% in the previous year[7] - Total operating revenue for Q3 2016 reached ¥446,004,584.53, a 28.8% increase from ¥346,269,788.76 in Q3 2015[30] - Net profit for Q3 2016 was ¥61,803,035.54, representing a 8.0% increase compared to ¥57,026,112.14 in Q3 2015[32] - Year-to-date net profit for the first nine months was ¥140,503,585.37, down 2.6% from ¥144,448,254.77 in the previous year[36] Assets and Liabilities - Total assets increased by 105.96% to CNY 2,041,817,331.17 compared to the end of the previous year[6] - Current assets rose to CNY 1,464,964,949.88, up from CNY 501,715,330.59, indicating a growth of about 192.5%[23] - Total liabilities rose to CNY 428,490,525.47 from CNY 344,550,622.44, representing an increase of about 24.4%[24] - Non-current assets totaled CNY 576,852,381.29, up from CNY 489,628,868.85, indicating an increase of approximately 17.8%[23] Cash Flow - Cash flow from operating activities for the first nine months increased by 79.62% to CNY 159,387,206.00 compared to the same period last year[6] - Total cash inflow from financing activities reached CNY 1,013,989,529.42, significantly higher than CNY 151,044,707.00 in the previous year[43] - Net cash flow from financing activities was CNY 886,716,745.94, compared to a mere CNY 21,539.64 in Q3 2015[43] - Cash received from sales and services was CNY 968,479,188.55, reflecting a growth of 15.8% from CNY 835,954,539.82 in Q3 2015[43] Shareholder Information - The total number of shareholders reached 53,283 by the end of the reporting period[11] - The largest shareholder, Ni Zhanggen, holds 59.02% of the shares, totaling 141,641,980 shares[11] - The company committed to repurchase all newly issued shares at no less than the secondary market price to stabilize stock prices post-IPO[17] - The lock-up period for major shareholders is set for 36 months, during which they cannot transfer or delegate management of their shares[19] Investment and Growth Plans - The company plans to continue expanding its market presence and investing in new product development to drive future growth[30] - The company anticipates potential significant changes in net profit compared to the previous year, but specific figures were not disclosed[20] Other Financial Metrics - Cash and cash equivalents increased by 949.97% to ¥1,010,952,985.08 due to new share issuance[13] - Income tax expenses rose by 116.75% to ¥43,857,087.01 as the corporate income tax rate was provisioned at 25%[15] - The company reported a total comprehensive income of ¥61,278,286.13 for Q3 2016, compared to ¥58,308,863.57 in Q3 2015[33]